How It Works

The MyoSure System Is Versatile

The MyoSure tissue removal system can be used for a wide range of procedures.

Image shows six different processes - adhesiolysis, directed biopsy, myomectomy, polypectomy, retained products of conception and septum

Why choose the MyoSure system?

Clear visualisation: The MyoSure system’s high quality optics provide a direct view of the uterine cavity, so you can easily see the anatomy and guide the procedure from start to finish.

Resect uterine tissue: While the stainless steel blade resects the unwanted tissue, the fluid management system simultaneously removes it from the uterine cavity using suction, providing a clear field of view. The device combined with suction continuously aspirates resected tissue through the device.

Side-facing cutting window: The side-facing cutting window is optimised to provide better tissue contact for efficient removal and to minimise the risk of perforation.

Preserves uterine function: Resection is done mechanically. Because no RF energy is used, uterine form and function is preserved and collected specimens remain intact.

One system, many procedures: With one system, you can treat a wide range of intrauterine pathologies.

NICE HMB Guidelines NG88 recommend1:

For women with suspected submucosal fibroids, polyps or endometrial pathology:

  • Ensure that hysteroscopy services are organised to enable progression to ‘see-and-treat’ hysteroscopy in a single setting if feasible.
  • Obtain an endometrial sample only in the context of diagnostic hysteroscopy. Do NOT offer ‘blind’ endometrial biopsy to women with HMB.
  1. National Institute for Health and Care Excellence (NICE). Heavy menstrual bleeding: assessment and management [NG88] Published March 2018

The MyoSure® tissue removal system, consisting of the MyoSure tissue removal devices (LITE, REACH, XL) and MyoSure controller, is intended for hysteroscopic intrauterine procedures by trained gynecologists to resect and remove tissue including submucous myomas, endometrial polyps, and retained products of conception. The MyoSure MANUAL hysteroscopic tissue removal device is intended for intrauterine use by a trained gynecologist to hysteroscopically resect and remove tissue, including focal lesions such as endometrial polyps and retained products of conception. MyoSure products are not appropriate for patients who are or may be pregnant, or are exhibiting pelvic infection, cervical malignancies, or previously diagnosed uterine cancer.

For more details on risks and benefits of the MyoSure system, MyoSure MANUAL tissue removal device, MyoSure hysteroscope and the Aquilex® fluid control system, please consult their respective IFUs.